Team Katusha has managed to escape a suspension from competition Eduard Vorganov became second rider of the team in 12 months to test positive for a banned performance enhancing drug. The rider was provisionally suspended on Friday after he tested positive for an adverse analytical finding for the anti-ischemic drug Meldonium in an out-of-competition test on January 14, 2016.

1. Special Report By http://www.isteroids.com/

2. Team Katusha has managed to escape a suspension from
competition Eduard Vorganov became second rider of the
team in 12 months to test positive for a banned
performance enhancing drug. The rider was provisionally
suspended on Friday after he tested positive for an adverse
analytical finding for the anti-ischemic drug Meldonium in
an out-of-competition test on January 14, 2016.
On Tuesday, the UCI Disciplinary Commission, an
independent branch of the world governing body of
cycling, issued its verdict. It ruled that the conditions for
the suspension of a team have not been met under Article
7.12.1 of the UCI Anti-Doping Rules that suggests a ban of
15-45 days of a team with two positive doping cases in the
space of a year

3. Team Katusha was facing a possible miss of racing that
might have included Vuelta a Andalucía, Omloop Het
Nieuwsblad, Vuelta a Andalucía, Omloop Het Nieuwsblad,
Kuurne-Brussel-Kuurne, Paris-Nice, Tirreno-Adriatico,
and other races.
Vitalii Abramov, Katusha team press officer, remarked we
of course are very happy with this decision of the UCI
Disciplinary Commission. Abramov said it was important
moment for our team and now we can continue to race
and focus on our goals and to move ahead with our
ambitions in this season.
The Russian team, despite escaping a suspension from the
UCI, could still face time away from races because it is a
member of the Movement for Credible Cycling (MPCC).